Christian M Harding

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

PLoS pathogens

The Journal of infectious diseases

Glycobiology

Proceedings of the National Academy of Sciences of the United States of America

VaxNewMo

Ohio State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

VaxNewMo Sep 05 2016

United States

CEO & Co-Founder

Education History

Ohio State University

United States

PHD

College of Charleston

United States

BSC

Publications

Paeton L Wantuch, Cory J Knoot, Lloyd S Robinson, Evgeny Vinogradov, Nichollas E Scott, Christian M Harding, David A Rosen
A heptavalent O-antigen bioconjugate vaccine exhibits differential functional antibody responses against diverse Klebsiella pneumoniae isolates. The Journal of infectious diseases (2024)
Paeton L Wantuch, Cory J Knoot, Lloyd S Robinson, Evgeny Vinogradov, Nichollas E Scott, Christian M Harding, David A Rosen
A heptavalent O-antigen bioconjugate vaccine exhibits differential functional antibody responses against diverse Klebsiella pneumoniae isolates. The Journal of infectious diseases (2024)
Paeton L Wantuch, Cory J Knoot, Lloyd S Robinson, Evgeny Vinogradov, Nichollas E Scott, Christian M Harding, David A Rosen
A heptavalent O-antigen bioconjugate vaccine exhibits differential functional antibody responses against diverse Klebsiella pneumoniae isolates. The Journal of infectious diseases (2024)
Paeton L Wantuch, Cory J Knoot, Lloyd S Robinson, Evgeny Vinogradov, Nichollas E Scott, Christian M Harding, David A Rosen
Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains of Klebsiella pneumoniae. PLoS pathogens 19 (5) (2023)
Paeton L Wantuch, Cory J Knoot, Lloyd S Robinson, Evgeny Vinogradov, Nichollas E Scott, Christian M Harding, David A Rosen
Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains of Klebsiella pneumoniae. PLoS pathogens 19 (5) (2023)
Paeton L Wantuch, Cory J Knoot, Lloyd S Robinson, Evgeny Vinogradov, Nichollas E Scott, Christian M Harding, David A Rosen
Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains of Klebsiella pneumoniae. PLoS pathogens 19 (5) (2023)
Paeton L Wantuch, Cory J Knoot, Lloyd S Robinson, Evgeny Vinogradov, Nichollas E Scott, Christian M Harding, David A Rosen
Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains of Klebsiella pneumoniae. PLoS pathogens 19 (5) (2023)
Cory J Knoot, Paeton L Wantuch, Lloyd S Robinson, David A Rosen, Nichollas E Scott, Christian M Harding
Discovery and characterization of a new class of O-linking oligosaccharyltransferases from the Moraxellaceae family. Glycobiology (2022)
Jeremy A Duke, Amy V Paschall, Lloyd S Robinson, Cory J Knoot, Evgeny V Vinogradov, Nichollas E Scott, Mario F Feldman, Fikri Y Avci, Christian M Harding
Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate Vaccine. ACS infectious diseases 7 (11) (2021)
Mario F Feldman, Anne E Mayer Bridwell, Nichollas E Scott, Evgeny Vinogradov, Samuel R McKee, Sthefany M Chavez, Joy Twentyman, Christina L Stallings, David A Rosen, Christian M Harding
A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae. Proceedings of the National Academy of Sciences of the United States of America 116 (37) (2019)

Christian M Harding.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christian M Harding